150 related articles for article (PubMed ID: 29437619)
1. Synergy between Pyrvinium Pamoate and Azoles against Exophiala dermatitidis.
Gao L; Sun Y; He C; Zeng T; Li M
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437619
[No Abstract] [Full Text] [Related]
2.
Sun Y; Gao L; Yuan M; Yuan L; Yang J; Zeng T
Front Cell Infect Microbiol; 2020; 10():576975. PubMed ID: 33194816
[TBL] [Abstract][Full Text] [Related]
3. In vitro interactions between 17-AAG and azoles against Exophiala dermatitidis.
Gao L; Sun Y; He C; Li M; Zeng T
Mycoses; 2018 Nov; 61(11):853-856. PubMed ID: 29998564
[TBL] [Abstract][Full Text] [Related]
4. In vitro interactions between IAP antagonist AT406 and azoles against planktonic cells and biofilms of pathogenic fungi Candida albicans and Exophiala dermatitidis.
Sun Y; Gao L; He C; Li M; Zeng T
Med Mycol; 2018 Nov; 56(8):1045-1049. PubMed ID: 29346584
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis.
Gao L; Sun Y; He C; Zeng T; Li M
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923863
[No Abstract] [Full Text] [Related]
6. Lonafarnib synergizes with azoles against Aspergillus spp. and Exophiala spp.
Qiao J; Sun Y; Gao L; He C; Zheng W
Med Mycol; 2018 Jun; 56(4):452-457. PubMed ID: 29420769
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs.
Meletiadis J; Meis JF; de Hoog GS; Verweij PE
Mycoses; 2000 Sep; 43(7-8):309-12. PubMed ID: 11036402
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of antifungal drugs against environmental Exophiala isolates and review of the literature.
Gülmez D; Doğan Ö; Boral B; Döğen A; İlkit M; de Hoog GS; Arikan-Akdagli S
Mycoses; 2018 Aug; 61(8):561-569. PubMed ID: 29611230
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
[TBL] [Abstract][Full Text] [Related]
10. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist.
Badali H; de Hoog GS; Sudhadham M; Meis JF
Med Mycol; 2011 Nov; 49(8):819-24. PubMed ID: 21612562
[TBL] [Abstract][Full Text] [Related]
11. Species diversity, antifungal susceptibility and phenotypic and genotypic characterisation of Exophiala spp. infecting patients in different medical centres in Brazil.
Silva WC; Gonçalves SS; Santos DW; Padovan AC; Bizerra FC; Melo AS
Mycoses; 2017 May; 60(5):328-337. PubMed ID: 28139861
[TBL] [Abstract][Full Text] [Related]
12. Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents.
Kirchhoff L; Olsowski M; Zilmans K; Dittmer S; Haase G; Sedlacek L; Steinmann E; Buer J; Rath PM; Steinmann J
Sci Rep; 2017 Feb; 7():42886. PubMed ID: 28211475
[TBL] [Abstract][Full Text] [Related]
13. Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis.
Deng S; Pan W; Liao W; de Hoog GS; Gerrits van den Ende AH; Vitale RG; Rafati H; Ilkit M; Van der Lee AH; Rijs AJ; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2016 Apr; 60(4):2346-51. PubMed ID: 26833164
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel azoles as potent antifungal agents.
Li L; Ding H; Wang B; Yu S; Zou Y; Chai X; Wu Q
Bioorg Med Chem Lett; 2014 Jan; 24(1):192-4. PubMed ID: 24332489
[TBL] [Abstract][Full Text] [Related]
15. Imidazolylchromanones containing non-benzylic oxime ethers: synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii.
Babazadeh-Qazijahani M; Badali H; Irannejad H; Afsarian MH; Emami S
Eur J Med Chem; 2014 Apr; 76():264-73. PubMed ID: 24583607
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the azole compounds against clinical fungal strains.
Ciok-Pater E; Gospodarek E; Modzelewska-Banachiewicz B; Ucherek M; Prazyńska M
Acta Pol Pharm; 2012; 69(3):565-7. PubMed ID: 22594272
[No Abstract] [Full Text] [Related]
17. [Study of the susceptibility of black yeasts of the Exophiala genus to antifungals using the Sensititre System].
Puerto JL; García-Martos P; Marín P; Sepúlveda A; García-Agudo R; Aoufi S
Rev Esp Quimioter; 2002 Sep; 15(3):268-71. PubMed ID: 12582431
[TBL] [Abstract][Full Text] [Related]
18. High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency.
Kondori N; Gilljam M; Lindblad A; Jönsson B; Moore ER; Wennerås C
J Clin Microbiol; 2011 Mar; 49(3):1004-9. PubMed ID: 21209163
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
[TBL] [Abstract][Full Text] [Related]
20. 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents.
Emami S; Foroumadi A; Falahati M; Lotfali E; Rajabalian S; Ebrahimi SA; Farahyar S; Shafiee A
Bioorg Med Chem Lett; 2008 Jan; 18(1):141-6. PubMed ID: 18032039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
